David John Fisher, Claire Louise Vale, Larysa H Rydzewska, Peter Godolphin, Neeraj Agarwal, Gerhardt Attard, Kim N. Chi, Noel W Clarke, Ian D. Davis, Karim Fizazi, Silke Gillessen, Nicholas David James, David John Matheson, Robert Oldroyd, Mahesh K. B. Parmar, Christopher Sweeney, Bertrand F. Tombal, Ian R White, Jayne F. Tierney. "Which patients with metastatic hormone-sensitive prostate cancer (mHSPC) benefit more from androgen receptor pathway inhibitors (ARPIs)? STOPCAP meta-analyses of individual participant data (IPD).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.20